GlassScriptPhysician profile
Bradley Tran
NPI 1366445991
$7,825.00
in general payments reported to CMS, 2019-2025
45 companies · $88.03 in 2025
The $88.03 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,328 · 2020: $933 · 2021: $978 · 2022: $993 · 2023: $791 · 2024: $2,716 · 2025: $88.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,128 · Travel and Lodging: $1,466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,128.46 |
| Travel and Lodging | $1,466.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,925.95 | 2020-2025 | Proclaim, Eterna |
| Boston Scientific Corporation | $1,019.05 | 2022-2024 | Intracept |
| Amgen INC. | $575.28 | 2019-2022 | |
| Genzyme Corporation | $440.82 | 2019-2022 | |
| Abbvie INC. | $311.65 | 2021-2024 | Botox |
| Novartis Pharmaceuticals Corporation | $286.20 | 2019-2021 | |
| Biogen, INC. | $246.24 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $228.55 | 2019-2022 | |
| Zyla Life Sciences, INC. | $217.86 | 2019-2020 | |
| Lundbeck LLC | $177.52 | 2020-2025 | Vyepti |
| Mdd US Operations, LLC | $175.56 | 2019-2020 | |
| Octapharma USA, INC. | $153.06 | 2022-2024 | Panzyga |
| Upsher-Smith Laboratories LLC | $151.22 | 2019-2021 | |
| Saluda Medical Americas, INC. | $143.46 | 2023 | Evoke Scs |
| Spr Therapeutics, INC | $136.92 | 2024 | Sprint Pns System |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.